Healthscore 601·6 metrosupdated 1h ago

New mRNA Vaccine Shows Promise in Reducing Melanoma Recurrence

The Intismeran Autogene vaccine, developed by Moderna and Merck, has shown a 49% reduction in melanoma recurrence when combined with Keytruda. This milestone in mRNA cancer treatment could pave the way for future cancer vaccines.

Where it's breaking

Los AngelesHampton RoadsBaltimoreBostonPhiladelphiaMiami–Ft. Lauderdale

Local coverage

Sources cited

Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.

What this is

A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.